Fatigue in adults with spinal muscular atrophy under treatment with nusinersen

5q-Associated spinal muscular atrophy is a hereditary neuromuscular disease leading to progressive muscle weakness in which fatigue occurs and affects quality of life. Treatment with the antisense oligonucleotide nusinersen has been shown to improve motor function. Fatigue can be measured within the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizina, K., Stolte, B., Totzeck, A., Bolz, S., Schlag, M., Ose, C., von Velsen, O., Kleinschnitz, C., Hagenacker, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338415/
https://www.ncbi.nlm.nih.gov/pubmed/32632203
http://dx.doi.org/10.1038/s41598-020-68051-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338415/
https://www.ncbi.nlm.nih.gov/pubmed/32632203
http://dx.doi.org/10.1038/s41598-020-68051-w

Ejemplares similares